Accordingly, targeting the thioredoxin system is an effective way to eradicate cancer cells without causing other collateral damage to surrounding normal cells (Zhang et al., 2017b; Bian et al., 2019; Ghareeb and Metanis, 2020; Jastrzab and Skrzydlewska, 2021). The gene discussed is TXN; the disease is cancer.